share_log

藥明生物：翌日披露報表

WUXI BIO: Next Day Disclosure Return

Hong Kong Stock Exchange ·  May 31 20:30
Summary by Futu AI
药明生物技术有限公司於2024年5月31日提交了翌日披露報表，披露了自2023年12月7日至2024年5月31日期間的股份購回情況。該公司在此期間進行了多次股份購回，但並未註銷這些股份。最後一次購回發生在2024年5月31日，當日購回股份數目為4,380,000股，每股價格介於HKD 11.14至HKD 11.66之間，總付出金額為HKD 49,724,740。自普通決議案通過以來，公司在香港聯合交易所購回的證券總數達到109,868,000股，佔已發行股份的2.5861%。根據報表，所有購回活動均符合香港聯合交易所的主板上市規則。
药明生物技术有限公司於2024年5月31日提交了翌日披露報表，披露了自2023年12月7日至2024年5月31日期間的股份購回情況。該公司在此期間進行了多次股份購回，但並未註銷這些股份。最後一次購回發生在2024年5月31日，當日購回股份數目為4,380,000股，每股價格介於HKD 11.14至HKD 11.66之間，總付出金額為HKD 49,724,740。自普通決議案通過以來，公司在香港聯合交易所購回的證券總數達到109,868,000股，佔已發行股份的2.5861%。根據報表，所有購回活動均符合香港聯合交易所的主板上市規則。
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON MAY 31, 2024 DISCLOSING SHARE REPURCHASES FOR THE PERIOD FROM DECEMBER 7, 2023 TO MAY 31, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on 31 May 2024. The number of shares repurchased on that date was 4,380,000 shares, priced between HKD 11.14 and HKD 11.66 for a total payment of HKD 49,724,740. Since the adoption of the Ordinary Resolution, the total number of securities repurchased by the Company on the Hong Kong Stock Exchange has reached 109,868,000 shares, representing 2.5861% of the issued shares. According to the report, all repurchases comply with the listing rules on the main board of the HKEx.
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON MAY 31, 2024 DISCLOSING SHARE REPURCHASES FOR THE PERIOD FROM DECEMBER 7, 2023 TO MAY 31, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on 31 May 2024. The number of shares repurchased on that date was 4,380,000 shares, priced between HKD 11.14 and HKD 11.66 for a total payment of HKD 49,724,740. Since the adoption of the Ordinary Resolution, the total number of securities repurchased by the Company on the Hong Kong Stock Exchange has reached 109,868,000 shares, representing 2.5861% of the issued shares. According to the report, all repurchases comply with the listing rules on the main board of the HKEx.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.